PCV56 COST-EFFECTIVENESS OF THE SUSTAINED-RELEASE PACLITAXEL-ELUTING ELUVIA STENT COMPARED TO THE PACLITAXEL-COATED ZILVER PTX STENT FOR ENDOVASCULAR TREATMENT OF PERIPHERAL ARTERY DISEASE: A GERMAN STATUTORY SICKNESS FUND PERSPECTIVE.
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.781
https://www.valueinhealthjournal.com/article/S1098-3015(19)33159-6/fulltext
Section Title :
Section Order :
10683
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33159-6&doi=10.1016/j.jval.2019.09.781